Skip to content

A Randomized Controlled Trial of AppS to Home Monitor Your Asthma

Integrating Patient-Reported Outcomes Into Routine Primary Care: Monitoring Asthma Between Visits

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04401332
Acronym
ASTHMA
Enrollment
413
Registered
2020-05-26
Start date
2020-07-21
Completion date
2023-04-30
Last updated
2026-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Keywords

patient-reported outcomes (PROs), mobile health (mHealth) apps, asthma, electronic health record (EHR), health information technology, implementation research, mobile phone

Brief summary

The objective of this study is to design, implement, and evaluate the impact of an adapted health information technology(IT)-enabled practice model for asthma symptom monitoring using patient-reported outcomes (PROs) in a primary care setting. Adults over 18 years of age with asthma will be recruited at primary care clinics and randomized to either 1) asthma symptom monitoring via the mobile health (mHealth) app; or 2) usual care. The investigators will collect data on patient-reported asthma quality of life and asthma-related healthcare utilization. We will also study barriers and facilitators to implementation of the mHealth app and health IT-enabled practice model.

Detailed description

The specific aims of this study are: 1. Adapt our existing health IT-enabled practice model for asthma symptom monitoring using PROs to a primary care population. The health IT-enabled practice model is comprised of the following: an mHealth app that can be installed on patients' smartphones that integrates into clinical workflow; and an asthma PRO dashboard in the electronic health record (EHR) for clinicians. 2. Implement the adapted health IT-enabled practice model in 7 primary care community clinics, identify a cohort of eligible asthma patients to participate, and train clinicians and clinical staff. 3. Rigorously evaluate the impact of this new health IT-enabled practice model using a randomized controlled trial study in which we enroll 500 asthma patients (250 intervention, 250 usual care) by primary care clinician. We will measure patient-reported asthma quality of life and asthma-related healthcare utilization (defined as urgent care and emergency room visits and hospitalizations) as our primary and secondary outcomes, respectively. We will use mixed methods to identify barriers and facilitators to implementation and factors that affect sustainable spread and scale as per the Non-adoption, Abandonment, Scale-up, Spread, and Sustainability (NASSS) framework.

Interventions

Asthma symptom monitoring via a clinically integrated mobile health (mHealth) application installed on participants' smartphones.

Sponsors

RAND
Lead SponsorOTHER
Brigham and Women's Hospital
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* English- or Spanish-speaking * 18 years of age * Regularly uses (most days) a compatible smartphone (iOS or Android) * Able to provide consent * Seen for primary care within the last 12 months at one of the 7 outpatient primary care clinics that are part of the Brigham \& Women's Hospital (BWH)/ Brigham \& Women's Faulkner Hospital (BWFH) practice-based research network. * At least one visit coded for asthma within 12 months prior to screening, including inpatient, emergency department, urgent care/walk-in, and specialist visits.

Exclusion criteria

* Deemed inappropriate for study, per judgment of the BWH/ BWFH primary care provider * Unable to provide consent

Design outcomes

Primary

MeasureTime frameDescription
Change in Asthma-related Quality of Life (Mini AQLQ Score) - 12 MonthsBaseline to 12 monthsMean change in asthma-related patient-reported quality of life from baseline to 12 months, assessed using the 15-item Mini Asthma Quality of Life Questionnaire (MiniAQLQ). MiniAQLQ scores range from 1 (worst quality of life) to 7 (best quality of life), with higher scores indicating better asthma-related quality of life. The MiniAQLQ score represents the mean of 15 items across four domains (symptoms, activity limitation, emotional function, and environmental stimuli).
Change in Asthma-related Quality of Life (Mini AQLQ Score) - 6 MonthsBaseline to 6 monthsMean change in asthma-related patient-reported quality of life from baseline to 6 months, assessed using the 15-item Mini Asthma Quality of Life Questionnaire (MiniAQLQ). MiniAQLQ scores range from 1 (worst quality of life) to 7 (best quality of life), with higher scores indicating better asthma-related quality of life. The MiniAQLQ score represents the mean of 15 items across four domains (symptoms, activity limitation, emotional function, and environmental stimuli).

Secondary

MeasureTime frameDescription
Asthma-related Healthcare UtilizationBaseline to 12 monthsMean number of asthma-related healthcare encounters per participant during the study period, including nonroutine asthma-related emergency department visits, urgent care visits, and hospitalizations (with asthma listed as the primary or secondary diagnosis) at MGB-affiliated institutions.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORRobert S Rudin, PhD

RAND

PRINCIPAL_INVESTIGATORAnuj K Dalal, MD

Massachusetts General Hospital

Participant flow

Recruitment details

Adults with a diagnosis of asthma who had a primary care provider at one of seven participating primary care clinics affiliated with a large academic health center in Boston, MA were identified and recruited between July 2020 and March 2022. Eligible patients completed screening and baseline questionnaires prior to enrollment. Reported recruitment and pre-assignment details apply to patient participants only.

Pre-assignment details

Primary care clinicians participated in delivering usual clinical care and supporting the intervention but were not enrolled as research participants and are therefore not included in enrollment counts or study data reported in this record. After providing informed consent and completing baseline questionnaires, 413 eligible patients were randomized to the intervention group (n = 211) or the usual care control group (n = 202).

Baseline characteristics

Characteristic
Age, Continuous52.2 Years
STANDARD_DEVIATION 15.4
Mini Asthma Quality of Life Questionnaire (MiniAQLQ) score5.04 Score on a scale
STANDARD_DEVIATION 1.27
Race/Ethnicity, Customized
Black
82 Participants
Race/Ethnicity, Customized
Hispanic
77 Participants
Race/Ethnicity, Customized
Other or missing
12 Participants
Race/Ethnicity, Customized
White
226 Participants
Sex: Female, Male
Female
164 Participants
Sex: Female, Male
Male
38 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 00 / 0
other
Total, other adverse events
0 / 00 / 0
serious
Total, serious adverse events
0 / 00 / 0

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 9, 2026